Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -8.57
- Piotroski Score 4.00
- Grade Neutral
- Symbol (PEAR)
- Company Pear Therapeutics, Inc.
- Price $0.03
- Changes Percentage (0%)
- Change -$0
- Day Low $0.03
- Day High $0.04
- Year High $6.74
Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a software-based treatment for chronic insomnia. The company is also developing a pipeline of 14 product candidates focusing on psychiatry, neurology, and outside of central nervous system therapeutic areas, such as gastrointestinal, oncology, and cardiovascular. Pear Therapeutics, Inc. was incorporated in 2013 and is based in Boston, Massachusetts.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 08/09/2023
- Fiscal Year End N/A
- Average Stock Price Target $6.50
- High Stock Price Target $8.00
- Low Stock Price Target $5.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Buy
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.36
- Trailing P/E Ratio -0.081111111111111
- Forward P/E Ratio -0.081111111111111
- P/E Growth -0.081111111111111
- Net Income $-23,740,000
Income Statement
Quarterly
Annual
Latest News of PEAR
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Australia news live: Easey Street murder suspect lands ahead of court appearance; transport costs fall everywhere except Sydney
Martin Farrer welcomes viewers to the live news blog, discussing Cbus super fund's governance review, voters' dissatisfaction with the government, the Easey Street murders suspect's arrival in Melbour...
By The Guardian | 23 hours ago -
SCOTUS appears to lean toward FDA in e-cig case
The Supreme Court heard arguments from Triton Distribution challenging FDA's regulation of flavored e-cigarette products. Justices seemed inclined to support the FDA's stance. A decision is expected b...
By POLITICO | 1 day ago -
American man, 72, believed to have gone overboard after he disappears...
A 72-year-old man went missing from a Princess Cruise ship on a voyage around Mexico. Officials suspect he fell overboard. Despite extensive searches, the man, traveling alone, has not been found....
By New York Post | 1 day ago
